Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02783950 · ClinicalTrials.gov registry record · NA
Genomics in Michigan Impacting Observation or Radiation
A NA study of Prostate Cancer, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 356
- Enrollment target
- 13
- Study locations
NCT02783950 is a NA study of Prostate Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 356 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (41% lower). The trial reports 13 study locations across 1 state.
The verdict
NCT02783950, a NA study of Prostate Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 356 participants
- Enrollment target
- 13
- Study locations
Study Summary
To determine the impact of Decipher test results on adjuvant treatment decisions of high-risk post-RP patients with undetectable post-op prostate specific antigen (PSA) compared to clinical factors alone.
Conditions Studied
Interventions
- OTHER Decipher Prostate Cancer Classifier
Study Locations (13)
Michigan
- University of Michigan Hospital and Health Systems - Ann Arbor
- Wayne State University/Karmanos Cancer Institute - Detroit
- Henry Ford Hospital - Detroit
- Urologic Consultants - Grand Rapids
- Urology Associates of Grand Rapids - Grand Rapids
- Michigan Urological Clinic - Grand Rapids
- Spectrum Health Medical Group- Urology - Grand Rapids
- Urology Surgeons, PC - Grand Rapids
- Comprehensive Medical Center, PLLC - Royal Oak
- Tri-City Urology - Saginaw
- Bay Area Urology Associates, PC - Traverse City
- Michigan Institute of Urology-Town Center - Troy
- IHA Urology at St. Joe's Ann Arbor - Ypsilanti
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2017-01-17 |
| Est. Completion | 2024-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02783950
The ClinicalTrials.gov registry entry for NCT02783950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 356 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (41% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Decipher Prostate Cancer Classifier is the first listed.
NCT02783950 reports 13 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02783950 about?
NCT02783950 is a clinical study titled "Genomics in Michigan Impacting Observation or Radiation". To determine the impact of Decipher test results on adjuvant treatment decisions of high-risk post-RP patients with undetectable post-op prostate specific antigen (PSA) compared to clinical factors alone.
What is the current status of trial NCT02783950?
This trial is currently completed. It is a NA study. The enrollment target is 356 participants. The study started on 2017-01-17. Estimated completion is 2024-04-02.
What conditions does trial NCT02783950 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT02783950?
The interventions under investigation include: Decipher Prostate Cancer Classifier (OTHER).
Who is sponsoring clinical trial NCT02783950?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02783950 being conducted?
This trial has 13 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.